Urocin®

  • For adults
  • Prescription only
  • For the prevention of recurrences of superficial bladder cancer after transurethral resection

Mitomycin from APOGEPHA

Packshots von Urocin®.

Product information

Properties of Urocin®

Active ingredient: Mitomycin

Indication: Urocin® is intended for intravesical use (inside the bladder) to prevent recurrence of superficial bladder cancer following transurethral resection (removal of tissue through the urethra).

Dosage, type and duration of use: Mitomycin should only be used by doctors who have experience with this treatment. It is important to make sure that the treatment is necessary. There are various treatment regimens for mitomycin, which differ in terms of the dosage used, the frequency of application and the duration of therapy.

Specialist group information

Click here to go to the specialist group login. You can see more detailed information after logging in.

Pack sizes

Pack sizes of Urocin®

Urocin® is available in 20 mg and 40 mg pack sizes:

Urocin® 20 mg

Packshot von Urocin® 20 mg.
PZN (pharmaceutical identification no Pack size Standard size
06980531 1 vial + bladder instillation system (N1) N1
06980548 4 vials + bladder instillation system  
06980554 6 vials + bladder instillation system (N2) N2

Urocin® 40 mg

Packshot von Urocin® 40 mg.
PZN (pharmaceutical identification no.) Pack size Standard size
14290964 1 vial + bladder instillation system (N1) N1
14290970 4 vials + bladder instillation system  
14290987 6 vials + bladder instillation system (N2) N2

Downloads

Free material for download

With just one click you can download the Usage and Technical Information as well as other service material and our patient film with valuable information:

Urocin® 20 mg

Urocin® 40 mg

General information